Compass Therapeutics (CMPX) announced the appointments of Arjun Prasad, MBA, MPH as Chief Commercial Officer and Cynthia Sirard, MD as Chief Medical Officer, both effective as of January 1, 2026. Most recently, Mr. Prasad was Chief Commercial Officer at Servier Pharmaceuticals. Dr. Sirard joins Compass from Leap Therapeutics, where she served as the Chief Medical Officer and spearheaded the development of first-in-class oncology agents.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMPX:
- Compass Therapeutics initiated with an Outperform at William Blair
- Compass Therapeutics: Emerging Bispecific Portfolio Positions Tovecimig to Redefine Second-Line Biliary Tract Cancer Standard of Care
- High-Conviction Buy on Compass Therapeutics: Near-Term Tovecimig Registration Data and Differentiated PD-1 x PD-L1 Bispecific Drive Favorable Risk-Reward
- Compass Therapeutics files $400M mixed securities shelf
- Promising Clinical Data and Market Positioning Drive Buy Rating for Compass Therapeutics